BACKGROUND: Patients with Barrett's oesophagus (BO) are at risk of oesophageal adenocarcinoma. Because the pattern of mucosal mucins changes during neoplastic progression, it may serve as a marker of intraepithelial neoplasia. AIMS: To determine the expression pattern of mucins in neoplastic BO epithelium (high grade dysplasia) and correlate it with the expression of apoptosis markers Bax and Bcl-2. METHODS: Thirty seven patients with BO were studied: 16 without intraepithelial neoplasia, six with high grade intraepithelial neoplasia (HGN), and 15 with infiltrating adenocarcinoma. Biopsies were obtained from squamous epithelium, Barrett's epithelium, and (when present) foci of suspected HGN or adenocarcinoma. MUC1-4, MUC5AC, MUC5B, MUC6, Bax, and Bcl-2 mRNA were determined by semiquantitative RT-PCR. MUC2, MUC5AC, and MUC6 protein was determined by immunoblotting. RESULTS: Mucin expression varied between neoplastic progression stages in BO. Mucin mRNA levels were low in squamous epithelium, except for MUC4, and were at least four times higher in BO and HGN (p<0.001), but less so in adenocarcinoma. MUC4 expression was significantly lower in BO than in normal squamous epithelium, whereas in HGN and adenocarcinoma, levels were significantly higher than in BO (p = 0.037). The Bax:Bcl-2 ratio was increased in HGN compared with BO (p = 0.04). MUC2, MUC5AC, and MUC6 protein values correlated with mRNA data. CONCLUSIONS: Mucin expression varies during the development of oesophageal adenocarcinoma in BO. MUC4 could serve as a tumour marker in this process. In contrast to animal studies, upregulation of MUC4 in HGN is associated with increased apoptosis, suggesting that MUC4 plays a minor role in apoptosis regulation in BO.
BACKGROUND:Patients with Barrett's oesophagus (BO) are at risk of oesophageal adenocarcinoma. Because the pattern of mucosal mucins changes during neoplastic progression, it may serve as a marker of intraepithelial neoplasia. AIMS: To determine the expression pattern of mucins in neoplastic BO epithelium (high grade dysplasia) and correlate it with the expression of apoptosis markers Bax and Bcl-2. METHODS: Thirty seven patients with BO were studied: 16 without intraepithelial neoplasia, six with high grade intraepithelial neoplasia (HGN), and 15 with infiltrating adenocarcinoma. Biopsies were obtained from squamous epithelium, Barrett's epithelium, and (when present) foci of suspected HGN or adenocarcinoma. MUC1-4, MUC5AC, MUC5B, MUC6, Bax, and Bcl-2 mRNA were determined by semiquantitative RT-PCR. MUC2, MUC5AC, and MUC6 protein was determined by immunoblotting. RESULTS:Mucin expression varied between neoplastic progression stages in BO. Mucin mRNA levels were low in squamous epithelium, except for MUC4, and were at least four times higher in BO and HGN (p<0.001), but less so in adenocarcinoma. MUC4 expression was significantly lower in BO than in normal squamous epithelium, whereas in HGN and adenocarcinoma, levels were significantly higher than in BO (p = 0.037). The Bax:Bcl-2 ratio was increased in HGN compared with BO (p = 0.04). MUC2, MUC5AC, and MUC6 protein values correlated with mRNA data. CONCLUSIONS:Mucin expression varies during the development of oesophageal adenocarcinoma in BO. MUC4 could serve as a tumour marker in this process. In contrast to animal studies, upregulation of MUC4 in HGN is associated with increased apoptosis, suggesting that MUC4 plays a minor role in apoptosis regulation in BO.
Authors: P Guillem; V Billeret; M P Buisine; J F Flejou; M Lecomte-Houcke; P Degand; J P Aubert; J P Triboulet; N Porchet Journal: Int J Cancer Date: 2000-12-15 Impact factor: 7.396
Authors: M C Copin; L Devisme; M P Buisine; C H Marquette; A Wurtz; J P Aubert; B Gosselin; N Porchet Journal: Int J Cancer Date: 2000-04-15 Impact factor: 7.396
Authors: A Walch; K Specht; K Bink; H Zitzelsberger; H Braselmann; M Bauer; M Aubele; H Stein; J R Siewert; H Höfler; M Werner Journal: Lab Invest Date: 2001-06 Impact factor: 5.662
Authors: C N Chinyama; R E Marshall; W J Owen; R C Mason; D Kothari; M L Wilkinson; J D Sanderson Journal: Histopathology Date: 1999-12 Impact factor: 5.087
Authors: Aafke H C van Roon; George C Mayne; Bas P L Wijnhoven; David I Watson; Mary P Leong; Gabriëlle E Neijman; Michael Z Michael; Andrew R McKay; David Astill; Damian J Hussey Journal: J Gastrointest Surg Date: 2008-05-02 Impact factor: 3.452
Authors: Sri Ganeshamurthy Thrumurthy; Christopher John Lewis; Susan Pritchard; Gordon Armstrong; Stephen Edwin Arthur Attwood Journal: Surg Endosc Date: 2012-01 Impact factor: 4.584
Authors: Andrew O'Neil; Christine P Petersen; Eunyoung Choi; Amy C Engevik; James R Goldenring Journal: J Histochem Cytochem Date: 2016-11-23 Impact factor: 2.479
Authors: N Moniaux; P Chaturvedi; G C Varshney; J L Meza; J F Rodriguez-Sierra; J-P Aubert; S K Batra Journal: Br J Cancer Date: 2007-06-26 Impact factor: 7.640